Forward Regulatory Plan 2021-2023: Regulations Amending the Food and Drug Regulations - Export and Transhipment of Drugs
Title of Regulatory Initiative
Regulations Amending the Food and Drug Regulations - Export and Transhipment of Drugs
Enabling Act
Food and Drugs Act
Description
The proposed amendments to the Food and Drug Regulations would extend drug establishment licensing and good manufacturing practices requirements to persons conducting licensable activities with drugs solely for export that are otherwise exempt from the application of the Food and Drugs Act (FDA) and Food and Drug Regulations under section 37 of the FDA. The proposed amendments would also clarify that drugs in transhipment through Canada must be in bond.
This regulatory initiative was identified by Health Canada in its Health and Biosciences Sector Regulatory Review Roadmap as ‘Establishment licensing scheme for drugs and medical devices’.
This regulatory initiative is associated with Health Canada’s stock review plan.
Regulatory cooperation efforts (domestic and international)
This proposal would contribute to meeting Canada commitments made during negotiations of the Canada-European Union Comprehensive Economic Trade Agreement.
Potential impacts on Canadians, including businesses
This proposal would maintain Canada's international reputation as a country who manufactures and exports good quality drugs.
Consultations
Drug establishment licence holders were consulted on export and transhipment proposal as part of a larger consultation initiative undertaken for proposed amendments related to drug establishment licence modernization between April and June 2019. A targeted stakeholder outreach was conducted in August 2020.
Canadians will have the opportunity to provide comments on the regulatory proposal during the Canada Gazette, Part I, public comment period, which is expected to take place in spring 2021.
Further information
Related information on the import and export of health products can be found on Health Canada’s website.
Additional information can be requested from the departmental contact.
Departmental contact information
Catherine Hudon
Director
Policy and Regulatory Strategies Directorate
Regulatory Operations and Enforcement Branch
Health Canada
Telephone: 343-540-8524
Email: hc.prsd-questionsdspr.sc@canada.ca
Date the regulatory initiative was first included in the Forward Regulatory
February 2021
Consult Health Canada's acts and regulations web page for:
- a list of acts and regulations administered by Health Canada
- further information on Health Canada's implementation of government-wide regulatory management initiatives
Consult the following for links to the Cabinet Directive on Regulation and supporting policies and guidance, and for information on government-wide regulatory initiatives implemented by departments and agencies across the Government of Canada:
To learn about upcoming or ongoing consultations on proposed federal regulations, visit:
Report a problem or mistake on this page
- Date modified: